IBM will report fourth-quarter 2025 earnings Wednesday afternoon, continuing a remarkable streak that has seen the 113-year-old technology giant reinvent itself for the artificial intelligence era. The company's stock touched all-time highs above $324 late last year, capping a 35% gain in 2025 that outpaced most technology peers—a sentence few would have predicted even three years ago.
The AI Transformation Takes Hold
At the center of IBM's resurgence is its rapidly growing AI business. In its most recent quarterly report, the company revealed that its generative AI "book of business"—representing contracts signed for AI-related products and services—had swelled to $9.5 billion, nearly doubling from the prior year.
This metric matters because it represents future revenue locked in through multi-year enterprise contracts. Unlike consumer AI products that can see demand evaporate quickly, IBM's enterprise AI commitments provide visibility into growth for years ahead.
"The conversion rate of the AI book of business into recognized revenue will be the key metric investors watch. A $9.5 billion backlog means nothing if it doesn't translate to the income statement."
— Industry analyst
What IBM's AI Actually Does
IBM's AI strategy differs meaningfully from consumer-focused competitors. The company's watsonx platform provides enterprise-grade AI capabilities including:
- Model training and deployment: Tools for building custom AI models on proprietary corporate data
- AI governance: Compliance and risk management features critical for regulated industries
- Integration services: Connecting AI capabilities to existing enterprise systems
- Consulting: IBM's massive services arm helps clients implement AI strategies
This enterprise focus means IBM isn't competing directly with ChatGPT for consumer attention. Instead, it's helping banks, healthcare systems, manufacturers, and government agencies deploy AI within their existing operations—a market that may ultimately prove larger and more durable than consumer applications.
The z17 Mainframe Cycle
IBM's AI story wouldn't be complete without discussing mainframes—the business that many assumed was dying but has instead become a growth driver. The z17 mainframe, launched in 2025, has posted what CEO Arvind Krishna called "the strongest two-quarter launch in history."
In the most recent quarter, IBM Z revenues grew 59% year-over-year. The z17 includes the Spyre accelerator, a custom chip that brings AI inferencing capabilities directly into the mainframe environment where much of the world's most critical transaction processing occurs.
Banks, insurance companies, and retailers that run core operations on IBM mainframes can now add AI capabilities without moving data to the cloud—addressing security and latency concerns that have slowed AI adoption in these sectors.
Q4 Expectations
Wall Street analysts project the following for IBM's fourth-quarter results:
- Revenue: Approximately $19.2 billion, representing nearly 10% year-over-year growth
- Gross margin: Expansion toward 60%, driven by higher software mix
- Free cash flow (full year): Expected to exceed $13 billion
The revenue growth rate would mark one of IBM's strongest quarters in years, driven by the combination of AI momentum and mainframe sales. The margin expansion reflects IBM's successful pivot toward higher-margin software and away from lower-margin hardware and services.
The Confluent Acquisition
Looking ahead, IBM announced in December its plan to acquire Confluent for $11 billion at $31 per share. The deal would bring Confluent's data streaming platform into IBM's portfolio, creating what the company calls a "smart data platform" for AI applications.
Data streaming is critical for AI because models need access to real-time information, not just historical datasets. Confluent's technology, originally developed at LinkedIn, is used by thousands of enterprises to move data between systems in real time.
The acquisition price—roughly 8 times revenue—reflects the strategic importance IBM places on owning this capability rather than partnering for it. Investors will listen for any updates on the deal's progress and expected integration timeline.
Challenges and Risks
Despite the positive momentum, IBM faces several challenges:
Consulting Competition
IBM's services business faces intense competition from Accenture, Deloitte, and specialized AI consultancies. While the AI book of business is growing, winning implementation work against aggressive competitors requires continuous investment.
Cloud Market Position
IBM Cloud remains a distant fourth behind AWS, Azure, and Google Cloud. While the company has found a niche in hybrid cloud—connecting on-premises systems to public cloud environments—it lacks the scale of larger competitors.
Technology Evolution
The AI landscape changes rapidly. Technologies that seem cutting-edge today can become commoditized quickly, and IBM must continue innovating to maintain premium pricing for its AI offerings.
Stock Outlook
IBM shares have pulled back about 3% over the past week from their November highs, trading near $295 heading into earnings. The stock trades at roughly 18 times forward earnings—a premium to its historical average but still a discount to faster-growing technology peers.
Analysts are generally positive on the stock, with price targets clustering in the $325-$350 range. The bull case rests on continued AI momentum and mainframe strength; the bear case focuses on competitive pressures in consulting and questions about the sustainability of mainframe demand once the z17 cycle matures.
What to Watch
Beyond the headline numbers, investors should focus on:
- AI book of business update: Has it grown beyond $9.5 billion?
- Conversion rate: How much AI backlog is converting to recognized revenue?
- z17 commentary: Any signs the mainframe cycle is peaking?
- 2026 guidance: What growth trajectory does management project?
- Confluent integration: Any updates on deal progress?
IBM's Q4 report will test whether the company's remarkable transformation can continue into 2026. For a company left for dead by many investors just a few years ago, the stakes—and the opportunity—have never been higher.
